-40%

*SEE DESCRIPTION* Fluke Biomedical Impulse 4000 ECG Analyzer

$ 475.2

Availability: 100 in stock
  • Item must be returned within: 30 Days
  • Model: Impulse 4000
  • Restocking Fee: No
  • Brand: Fluke
  • Return shipping will be paid by: Buyer
  • All returns accepted: Returns Accepted
  • Refund will be given as: Money back or replacement (buyer's choice)
  • Condition: SELLING FOR PARTS DUE TO INABILITY TO TEST ITEM. ITEM MAY OR MAY NOT FUNCTION PROPERLY. THE SCREEN IS CRACKED AND DISCOLORED AS WELL AS SOME DAMAGE TO SOME OF CHARGING PORTS AND PINS. *ONE OF THE ITEMS RATTLES ON THE INSIDE.* SEE PHOTOS FOR EVERYTHING INCLUDED. NO ADDITIONAL PARTS OR ACCESSORIES. PLEASE MESSAGE BEFORE PURCHASING IF YOU HAVE ANY QUESTIONS. THANK YOU!
  • MPN: Does Not Apply

    Description

    SEE PHOTOS IF YOU HAVE ANY QUESTIONS PLEASE MESSAGE BEFORE PURCHASING. THANK YOU!
    PRODUCT DISCLAIMER & PARTS / REPAIR.
    We do not load software nor transfer ownership of items. We do not reset passwords. Items sold for Parts / Repair are given a general inspection power on testing(UNLESS SPECIFIED ITEM UNTESTED) and basic description. Keep in mind Parts / Repair items are sold as / is no warranty or guarantee and may have additional issues beyond the item description. Keep in mind we are not the original owners of these items so we have limited knowledge of functionality.
    Section 758.6 of the Export Administration Regulations (EAR) discusses when an exporter must incorporate a Destination Control Statement on certain export documents.  The EAR provides the following statement to exporters:
    “These items are controlled by the U.S. Government and authorized for export only to the country of ultimate destination for use by the ultimate consignee or end-user(s) herein identified. They may not be resold, transferred, or otherwise disposed of, to any other country or to any person other than the authorized ultimate consignee or end-user(s), either in their original form or after being incorporated into other items, without first obtaining approval from the U.S. government or as otherwise authorized by U.S. law and regulations.”